POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for ...

Sumeet Bagadia recommends five shares to buy today —Prism Johnson, Pasupati Acrylon Ltd, Dhunseri Investments Ltd, Epigral ...

Sumeet Bagadia recommends five shares to buy today —Prism Johnson, Pasupati Acrylon Ltd, Dhunseri Investments Ltd, Epigral ...

Start your day ahead of the curve with our sharp, curated morning news roundup. Get the key stories from top newspapers and ...

DSP-1083 is under clinical development by Sumitomo Pharma and currently in Phase II for Parkinson’s Disease. According to GlobalData, Phase II drugs for Parkinson’s Disease have a 41% phase transition ...

Indian equity indices rose on Tuesday, with the Nifty 50 up 0.42% and the Sensex up 0.44%, driven by IT and pharma stocks.

The Nifty Pharma index closed on a positive note on Tuesday. Shares of Divi's Laboratories Ltd.(up 4.89 per cent), Granules ...

Dainippon Sumitomo Pharma (DSP), and Evotec. Those deals had already made Exscientia one of the most well-funded players in the AI drug discovery category even before it closed a $510 million ...

Dainippon Sumitomo Pharma (DSP), and Evotec. Behind them are more than 25 active projects in cancer, inflammation and rare diseases, according to the company's IPO prospectus. It has already taken ...

Asian stock markets are trading mostly higher on Friday, following the broadly positive cues from global markets overnight, as traders are upbeat about the rising prospects of an interest rate cut by ...

Professor of Psychiatry and Molecular Medicine, Department of Psychiatry; Hofstra North Shore Long Island School of Medicine, Hempstead, New York; Medical Director, Recognition and Prevention ...